Zynex, Inc. announced the appointment of Steven Dyson as its new Chief Executive Officer, with his employment set to begin on August 18, 2025. Thomas Sandgaard, the company's Founder and Chairman of the Board since 1996, will transition from day-to-day operations but will remain actively involved as Chairman and Chair of the Board's Technology Committee. This leadership change marks a significant strategic shift for the company.
Steven Dyson brings over 25 years of experience in the medical technology sector, primarily through his leadership at Apax, a global private equity firm. His background includes key roles in acquiring, growing, and exiting numerous healthcare and medtech companies globally, with board and transaction experience across various international firms. Dyson holds a B.A. from Oxford University and a Ph.D. from Cambridge University.
Thomas Sandgaard expressed excitement for Dyson's deep expertise and proven track record, stating that his leadership will be instrumental in refocusing Zynex's business strategy towards an optimized payer mix and returning the company to a strong growth trajectory. Steven Dyson affirmed his honor to join the team and lead Zynex back to growth, building on the strong foundation established by Sandgaard.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.